0001209191-21-026217.txt : 20210409 0001209191-21-026217.hdr.sgml : 20210409 20210409161409 ACCESSION NUMBER: 0001209191-21-026217 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210407 FILED AS OF DATE: 20210409 DATE AS OF CHANGE: 20210409 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Renaud Ronald C JR CENTRAL INDEX KEY: 0001354434 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38550 FILM NUMBER: 21817991 MAIL ADDRESS: STREET 1: C/O IDENIX PHARMACEUTICALS, INC. STREET 2: 60 HAMPSHIRE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Translate Bio, Inc. CENTRAL INDEX KEY: 0001693415 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 611807780 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 29 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 617-945-7361 MAIL ADDRESS: STREET 1: 29 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: RaNA Therapeutics, Inc. DATE OF NAME CHANGE: 20161228 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-04-07 0 0001693415 Translate Bio, Inc. TBIO 0001354434 Renaud Ronald C JR C/O TRANSLATE BIO, INC. 29 HARTWELL AVE LEXINGTON MA 02421 1 1 0 0 Chief Executive Officer Common Stock 2021-04-07 4 M 0 9026 7.39 A 503321 D Common Stock 409913 I By Ronald Renuad 2014 Irrevocable Family Trust Common Stock 40909 I By Ronald C. Renaud, Jr. Trust - 2007 Stock Option (right to buy) 7.39 2021-04-07 4 M 0 9026 0.00 D 2027-12-21 Common Stock 9026 1071009 D This option was granted on December 22, 2017. The shares underlying the option vested over four years in equal monthly installments through March 9, 2021. /s/ Paul Burgess, as attorney-in-fact for Ronald C. Renaud, Jr. 2021-04-08